The buying is small-scale and from asset managers rather than high-conviction activist or specialist funds. Monitor next quarter's 13F for follow-through and any insider buying to confirm the thesis.
CGON drugs
CGON drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $64.06entry
- T+1 · 13d ago +5.70%α +4.05% · $67.71
- T+5 · 7d ago +13.39%α +13.98% · $72.64
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Four institutional asset managers increased their CG Oncology positions in Q3 2026, with aggregate buying of $4.4M versus $861K in selling from one trimmer. The cluster is small in dollar terms relative to the $5.6B market cap and lacks insider buying corroboration, limiting conviction.
Key Financial Metrics
Institutional Positions
Net institutional flow: $4.4M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Principal Financial Group | DOUBLED | +420.2% | $2.1M | $1.7M |
| Creative Planning | ADD | +77% | $1.6M | $697.0K |
| Alps Advisors | ADD | +31.7% | $8.3M | $2.0M |
| Farther Finance Advisors | ADD | +31% | $3.0K | $631.00 |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Strs Ohio | TRIM | -58.2% | $1.5M | -$861.0K |
Key Facts
- 4 institutional buyers added $4.4M net, led by Principal Financial Group doubling its position (+420.2% shares, +$1.7M)
- 1 seller (Strs Ohio) trimmed 58.2% of its stake, reducing value by $861K
- All participants are asset managers, not activist or event-driven funds
- Insider-13F confluence score is 11/100 (divergent), with zero open-market insider buyers
- 13F data is as of Q3 2026 quarter-end, reported with a 45-day lag
Financial Impact
Net institutional buying of $4.4M against $861K in selling; total buyer holdings of $12.0M represent ~0.2% of market cap
Risk Factors
- 13F data is stale (45-day reporting lag); positions may have been unwound since quarter-end
- No insider buying to corroborate the institutional signal
- Cluster size is trivial relative to $5.6B market cap, unlikely to drive stock price alone
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CGON-2026-Q3 |
Track record
25 reports on CGON
6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +26.33% at T+20 after the Jun 12, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 settles Dec 15
- Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 settles Dec 7
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 settles Dec 7
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Viewing Entry $64.06 settles Dec 2
- Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 settles Nov 17
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 ▲ +24.31% +25.47% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 ▲ +18.39% +21.66% vs SPY
- Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 ▲ +0.69% +1.29% vs SPY
- Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 ▲ +0.69% +1.29% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers